Nano-Ditech Corporation manufactures rapid immuno-diagnostic products.

Nano-Ditech Corporation

Nano Ditech Corp | 276 followers on LinkedIn. Founded in 2002, Nano-Ditech Corp specializes in the development and manufacture of high quality rapid immuno-diagnostic products to serve the point-of-care market place including medical professionals, physicians, clinical laboratories and hospitals.  Nano-Ditech is proud to be among the few that have a track record for successfully developing test devices through the development of raw materials and obtaining US FDA and CE clearance. Nano-Ditech’s unique techniques have enabled us to rapidly develop all classes of monoclonal antibodies for each of the illicit drugs and cardiac disease markers to be specifically used for the rapid assay.

This is Jina Ha. I am a Regulatory Specialist in US. I've been work as RA in medical devices area for 9yrs.

Jina Ha

Nano Ditech Corp

We’re live at Medica MEDICA - Leading International Trade Fair in Düsseldorf! Come visit our booth to explore our latest innovations in IVD solutions. Our team is excited to connect and discuss how we can support your diagnostic needs. See you there! #Medica2024 #IVD #Diagnostics

Precision Biosensor

[World Stroke Day] Today, October 29th, is World Stroke Day. Stroke remains one of the leading causes of death worldwide, underscoring the critical need for early detection. With the Exdia SOB panel, you can monitor key markers—Troponin I, NT-proBNP, and D-dimer—in a single test, supporting efficient and timely stroke management. Save time, be proactive, and prioritize patient care. #WorldStrokeDay #StrokeAwareness #IVD #POCTesting #Cardiac #Hearthealth For more information: https://lnkd.in/eMXKva7E Picture courtesy: World Stroke Campaign

🚨 It’s almost that time of year again – #Medica2024 is just around the corner! We’re excited to invite you to visit our showcase booth, where you can explore our cutting-edge Immunodiagnostic “Exdia TRF Plus” and Clinical Chemistry “Exdia PT10” Point-of-Care (POC) platforms. Joining us at the event will be our US-based company, Nano Ditech Corp who will be presenting their “Multi Cardiac Marker Tests” alongside their newly 510(k) US FDA-approved rapid tests. 📅 Want to book an appointment? Feel free to send us a direct message via LinkedIn or contact our marketing manager Ms. Yujin Lee at yjlee@precision-bio.com . We look forward to seeing you soon in Düsseldorf, Germany! #Medica #IVD #MedTech #Exhibition #HealthcareInnovation #PrecisionBio #NanoDitech

[Recap from the Korean Medical Practitioners Association Event] We were thrilled to participate in the Korean Medical Practitioners Association event on October 13th,2024 at the Swiss Grand Hotel Convention Center in Seoul, Korea. It was a valuable opportunity to reconnect with our local Exdia PT10 distributors and KOLs, to discuss the latest trends and advancements in the medical industry. As the only locally manufactured Clinical Chemistry POC solution, Exdia PT10 continues to lead the Korean market, praised for its: ✅ Versatile test panel menu ✅ Reliable and fast measurement ✅ User-friendly interface Dr. Yongtaek Oh, our Director of Marketing Strategy, reflected on the event: “The Korean Medical Association Congress provided a fantastic platform for us to showcase our innovative technologies. It was a great opportunity to connect with new doctors and present our cutting-edge solutions.” We look forward to continuing our efforts in advancing medical diagnostics and supporting healthcare professionals with reliable, high-quality solutions. For more information regarding Exdia PT10 and our multiplex test menu click: https://lnkd.in/eEFjQzwZ #IVD #ClinicalChemistry #laboratory #medicaldevice #pathology #POCT #pointofcaretesting #ExdiaPT10 #Exdia

[Breast Cancer Awareness Month] Breast cancer often develops without any noticeable symptoms, making regular screenings essential. Various tests, such as mammograms, breast ultrasounds, and MRIs, are used to detect abnormalities. If something concerning is found, further testing is required to confirm whether it's cancer. Once diagnosed, lab work plays a critical role. While blood tests don’t diagnose breast cancer, they help assess overall health, monitor organ function, and guide treatment decisions. For instance, abnormal liver function tests could indicate that the cancer has spread. 'Exdia PT10' is delivering accurate AST and ALT values along with other key organ markers in just 10 minutes, using only a small blood sample, Exdia PT10 has proven its reliability through rigorous studies across multiple countries in Europe and Asia. Early detection and precise diagnostics can save lives. Let's prioritize our health and encourage regular screenings. For more information: https://lnkd.in/ebVqg6ey #WomensHealth #Breastcancer #BreastCancerAwareness #thinkpink #bccww #BCSM #YoungAdultCancer #IVD #BloodTest #clinicalchemistry

[World Heart Day] In recognition of World Heart Day, we’re encouraging everyone to "Use Heart for Action" and prioritize cardiovascular health. Cardiovascular diseases continue to be the leading cause of mortality globally, but through collective efforts, we can drive impactful change. At Precision Biosensor, we are committed to empowering healthcare professionals with advanced diagnostic solutions that enable early and accurate detection of heart conditions, ultimately improving patient outcomes. Click here: https://lnkd.in/ey8eKQHC Let’s work together to make heart health a global priority—every action makes a difference. #WorldHeartDay #CardiovascularHealth #IVD #Health #heartdisease #diabetes #cardiology Picture Courtesy: World Heart Federation

Empower your teams with enhanced diagnostic capabilities this respiratory season. As winter respiratory season approaches, it’s essential to equip your teams with the right tools for effective and efficient patient care. Transform operational efficiency and improve patient outcomes with Exdia TRF Plus high-performance respiratory portfolio: ✅COVID-19 ✅Flu A & B ✅Strep A —all on a single, fully connected, easy-to-use platform with built-in quality control. Additionally, we offer a standalone ✅ RSV test, 510(k) FDA cleared and CLIA-Waived, to complete our comprehensive respiratory portfolio. Ensure your team is prepared for the season ahead! Empowering Patients and Clinicians with Faster, Reliable Results The Exdia TRF Plus Platform is transforming clinical diagnostics with high-performance across multiple assays, providing crucial support to physicians, especially during the challenging winter months. By delivering rapid results where they’re needed most, clinicians can triage patients with respiratory symptoms more efficiently. Discover how the Exdia TRF Plus Platform stands out from other solutions in a comprehensive validation study from Switzerland. Lear more here: https://lnkd.in/dDmwXWj3

Since 2011, September has been recognized as Sepsis Awareness Month by the Sepsis Alliance, dedicated to increasing awareness of sepsis—the leading cause of death in U.S. hospitals. What is Sepsis? Sepsis is the body’s extreme and life-threatening response to infection, leading to organ dysfunction due to an uncontrolled immune response. Despite being underrecognized, sepsis is a major global health issue, responsible for one in five deaths worldwide. Exdia Sepsis Solution: Improve patient care and enhance sepsis management at your institution with Exdia PCT and CRP. Procalcitonin (PCT) and C-reactive Protein (CRP) are the preferred biomarkers for sepsis diagnosis, providing both diagnostic and prognostic insights. It empowers Emergency and Intensive Care clinicians to make informed decisions about antibiotic therapy, potentially leading to better clinical outcomes. #Sepsis #Procalcitonin #PCT #IVD #Antibiotictherapy #Exdia #WorldSepsisDay #SepsisAwareness #CRP

We are thrilled to announce that Nano-Ditech, has achieved 510(k) FDA clearance and CLIA-Waiver certification for the Nano-Check™ RSV Test, a groundbreaking diagnostic product for Respiratory Syncytial Virus (RSV) infection. The Nano-Check™ RSV Test is a rapid diagnostic tool designed for patients exhibiting RSV symptoms such as coughing, sneezing, and a runny nose. This test allows for the collection of a nasal sample and delivers visual confirmation of infection within just 15 minutes. Its CLIA-Waiver certification means it can be conveniently used in pharmacies and non-specialized laboratories. One of the notable advantages of the Nano-Check™ RSV Test is its applicability to adults aged 60 years and older, a demographic significantly impacted by RSV. With local clinical trials conducted in the U.S., we aim to address the alarming statistics of 60,000 to 160,000 hospitalizations and 6,000 to 10,000 deaths annually among adults aged 65 and older due to RSV. This accomplishment follows the FDA 510(k) clearance of the Nano-Check™ COVID-19 Antigen Test in January and the additional CLIA-Waiver clearance secured in June. Furthermore, our Nano-Check™ Influenza+COVID-19 Dual Test received an Emergency Use Authorization (EUA). We remain committed to providing innovative and accessible diagnostic solutions to improve public health. hashtag #healthcareinnovation hashtag #RSV hashtag #diagnostics hashtag #FDAclearance hashtag #CLIAwaiver hashtag #NanoDitech hashtag #IVD hashtag #respiratorysyncytialvirus hashtag #FDAclearance hashtag #virus hashtag #POCT hashtag #rapidtest hashtag #stopRSV

MedWatch has brought the news of our collaboration with Precision Biosensor . We are excited to work together in order to bring hospital-level care to patients in their homes in the South Korean market. Feel free to give it a read here: https://lnkd.in/dTB5C5yD #innovation #health #medtech #diagnostics #homehealthcare #hospitalathome

news impact assignment basic	general
public peers	general	Nov 19, 2024 6:50 AM	5b4a4120
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 19, 2024 6:50 AM	db69fbb7
crunchbase trigger	general	Nov 19, 2024 6:50 AM	ac740730
crunchbase profile	general
li profile	general	Nov 19, 2024 6:50 AM	0467003a
translate crunchbase fundingrounds	general
peers	general	Nov 19, 2024 6:50 AM	21d3ef3c
news basic	general	Nov 19, 2024 6:50 AM	48d9b3c5
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

NANO

COM:NANODITECH

Nano-Ditech Corporation